Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes

Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure

(2015) Alireza Aslani et al.   HPB

Cachexia in pancreatic cancer: new treatment options and measures of success

(2015) Kenneth C.H. Fearon et al.   HPB

Anorexia–cachexia syndrome in pancreatic cancer: Recent advances and new pharmacological approach

(2014) Ilaria Ronga et al.   Advances in Medical Sciences

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

(2014) Ya-Chin Hou et al.   CANCER

Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

(2014) M. F. Sanmamed et al.   CLINICAL CANCER RESEARCH

Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer

(2014) Yutaka Fujiwara et al.   PLoS One

Pancreatic cancer cachexia: a review of mechanisms and therapeutics

(2014) Carlyn R. Tan et al.   Frontiers in Physiology

Cancer cachexia—pathophysiology and management

(2013) Hajime Suzuki et al.   JOURNAL OF GASTROENTEROLOGY

Favorable Responses to Tocilizumab in Two Patients With Cancer-Related Cachexia

(2013) Haruhiko Hirata et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients

(2012) John P Williams et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia

(2012) Andrea Bonetto et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival

(2012) Theodore H. Welling et al.   CANCER INVESTIGATION

Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)

(2012) David Páez et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia

(2012) Katsutoshi Ando et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem

(2012) Maria Tsoli et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Interleukin-8, a promising predictor for prognosis of pancreatic cancer

(2012) Ying Chen   WORLD JOURNAL OF GASTROENTEROLOGY

Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?

(2011) Celena Scheede-Bergdahl et al.   CLINICAL NUTRITION

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

(2011) Trevor J Bayliss et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Cancer Cachexia: Mechanisms and Clinical Implications

(2011) Claire L. Donohoe et al.   Gastroenterology Research and Practice

Serum cytokine profiles in patients with prostate carcinoma

(2011) ERI TAZAKI et al.   Experimental and Therapeutic Medicine

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

(2010) Karsten Lenk et al.   Journal of Cachexia Sarcopenia and Muscle

Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function

(2009) Jeannine Bachmann et al.   BMC CANCER

Association of Interleukin-8 with Cachexia from Patients with Low-Third Gastric Cancer

(2009) Bo Song et al.   COMPARATIVE AND FUNCTIONAL GENOMICS

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY

Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc Min/+ mouse

(2008) Kristen A. Baltgalvis et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY